Curcumin Prevents Renal Damage of l‐NAME Induced Hypertension in by Reducing MMP‐2 and MMP‐9

ABSTRACT In the present study, we investigated whether curcumin administration would interfere with the main renal features of l‐NAME‐induced hypertension model. For this purpose, we conducted both in vitro and in vivo experiments to evaluate renal indicators of inflammation, oxidative stress, and m...

Full description

Saved in:

Bibliographic Details
Published in:	Cell biochemistry and function Vol. 42; no. 7; pp. e4119 - n/a
Main Authors:	Pereira, Bruna Pinheiro, Silva, Alessandra Oliveira, Awata, Wanessa Mayumi Carvalho, Pimenta, Gustavo Félix, Ribeiro, Jéssyca Milene, Faria Almeida, Carolina Aparecida, Antonietto, Carla Renata Kitanishi, Reis, Luis Felipe Cunha, Esteves, Alessandra, Torres, Larissa Helena Lobo, Araújo Paula, Fernanda Borges, Ruginsk, Sílvia Graciela, Tirapelli, Carlos Renato, Rizzi, Ellen, Ceron, Carla Speroni
Format:	Journal Article
Language:	English
Published:	England 01-09-2024
Subjects:	Animals Curcumin - pharmacology Hypertension - chemically induced Hypertension - drug therapy Hypertension - metabolism Kidney - drug effects Kidney - metabolism Kidney - pathology kidney damage Kidney Diseases - chemically induced Kidney Diseases - drug therapy Kidney Diseases - metabolism Kidney Diseases - pathology Kidney Diseases - prevention & control l‐NAME induced hypertension Male Matrix Metalloproteinase 2 - metabolism Matrix Metalloproteinase 9 - metabolism matrix metalloproteinases NG-Nitroarginine Methyl Ester - pharmacology oxidative stress Oxidative Stress - drug effects Rats Rats, Wistar kidney damage matrix metalloproteinases oxidative stress l‐NAME induced hypertension
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	ABSTRACT In the present study, we investigated whether curcumin administration would interfere with the main renal features of l‐NAME‐induced hypertension model. For this purpose, we conducted both in vitro and in vivo experiments to evaluate renal indicators of inflammation, oxidative stress, and metalloproteinases (MMPs) expression/activity. Hypertension was induced by l‐NAME (70 mg/kg/day), and Wistar rats from both control and hypertensive groups were treated with curcumin (50 or 100 mg/kg/day; gavage) or vehicle for 14 days. Blood and kidneys were collected to determine serum creatinine levels, histological alterations, oxidative stress, MMPs expression and activity, and ED1 expression. l‐NAME increased blood pressure, but both doses of curcumin treatment reduced these values. l‐NAME treatment increased creatinine levels, glomeruli area, Bowman's space, kidney MMP‐2 activity, as well as MMP‐9 and ED1 expression, and reduced the number of glomeruli. Curcumin treatment prevented the increase in creatinine levels, MMP‐2 activity, and reduced MMP‐2, MMP‐9, ED1, and superoxide levels, as well as increased superoxide dismutase activity and partially prevented glomeruli alterations. Moreover, curcumin directly inhibited MMP‐2 activity in vitro. Thus, our main findings demonstrate that curcumin reduced l‐NAME‐induced hypertension and renal glomerular alterations, inhibited MMP‐2 and MMP‐9 expression/activity, and reduced oxidative stress and inflammatory processes, which may indirectly impact hypertension‐induced renal outcomes. Significance Statement Curcumin is an intense yellow polyphenol isolated from the plant Curcuma longa Linn. that presents several pharmacological actions. The use of curcumin as a supplement may help to prevent hypertension‐induced kidney damage. This is the first study to show that curcumin prevents renal damage in an l‐NAME hypertension model by reducing MMP‐2, MMP‐9, and ED‐1 macrophage marker levels. Additionally, we first demonstrated a direct inhibition of MMP‐2 by curcumin in vitro. Our results suggest that curcumin may have clinical application as a supplement for hypertension‐induced kidney damage.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0263-6484 1099-0844 1099-0844
DOI:	10.1002/cbf.4119